#USA #New York #FIZE Medical #FIZE kUO #SCCM 2026

FIZE Medical to Present at the Society of Critical Care Medicine Congress 2026

FIZE Medical is excited to announce that it will be showcasing important clinical research at the upcoming Society of Critical Care Medicine (SCCM) Congress, scheduled for March 22-24, 2026. An abstract titled "Minute-by-Minute Measurement of Furosemide Urine Response Predicts 30-Day Mortality in ICU Patients" has been accepted for oral presentation. The presentation will be delivered by Dr. Ohad Gabbay, a senior physician at the Soroka Medical Center's General Intensive Care Department, on March 24.

The research highlighted in this abstract emphasizes the significance of monitoring urine output in critically ill patients, using the innovative FIZE kUO® platform. This advanced method allows for real-time monitoring and provides healthcare professionals with immediate insights into patients' kidney function, aiding in critical decision-making.

Insights from the Research

The abstract presents compelling evidence that a rapid urine output response to furosemide, monitored continuously through the FIZE kUO® system, is significantly linked to 30-day patient mortality rates. According to Prof. Moti Klein, who leads the research and serves as the Chair of Anesthesiology and Intensive Care at Soroka Medical Center, "Our findings underscore how timely monitoring of urine output can serve as a vital indicator of kidney health and patient risk in intensive care settings."

The study involved a retrospective analysis of adult ICU patients who were administered intravenous furosemide, focusing on the patients' urine output during the critical first 15 minutes after the drug was given. The results indicated that those exhibiting higher urine output soon after furosemide treatment had improved survival outcomes, suggesting a potential new approach to prognostic monitoring in critical care.

The Role of FIZE Medical

FIZE Medical is at the forefront of medical technology, concentrating on enhancing fluid management techniques within the field of critical care medicine. Their flagship FIZE kUO® platform is engineered to deliver continuous and high-resolution data on urine output directly integrated within electronic medical records (EMR). This capability allows for the early identification of renal complications and enhances the administration of fluid therapies.

Dror Zerem, CEO of FIZE Medical, stated, "This research highlights the critical need for continuous urine output data. By leveraging our technology, healthcare providers can recognize patient deterioration much sooner and manage fluids and hemodynamics more effectively."

During the SCCM Congress, FIZE Medical will set up an exhibition where attendees can gain hands-on experience with the FIZE kUO® device. This is a unique opportunity for healthcare practitioners to see firsthand how continuous urine output monitoring can play a pivotal role in assessing kidney function and improving overall patient care in critical scenarios.

Future of Critical Care

FIZE Medical aims to bridge the critical data gaps in ICUs by using real-time, high-resolution patient data for enhanced, personalized care. As the landscape of medical technology continues to evolve, FIZE Medical's commitment to innovative solutions places them at the center of advancing healthcare outcomes. The insights gained from the upcoming congress will further outline how such advancements can help redefine patient management strategies in intensive care settings, making proactive approaches more prominent in practice.

In summary, FIZE Medical is eager to present its findings at SCCM 2026 and contribute to the ongoing dialogue on improving patient outcomes in critical care through the use of cutting-edge medical technology. This event not only represents a milestone for the company but also marks an important step forward in the treatment and management of critically ill patients worldwide.